Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14251-14300 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03993353
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
PHASE2
Active, not recruiting
7 participants
Started: Apr 7, 2020 · Completed: Mar 1, 2029
12 conditions
1 sponsor
1 location
NCT04158440
Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC
PHASE3
Active, not recruiting
501 participants
Started: Apr 7, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04272801
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
PHASE2
Active, not recruiting
84 participants
Started: Apr 7, 2020 · Completed: Jun 1, 2026
1 condition
2 sponsors
2 locations
NCT04325828
A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
PHASE2
Active, not recruiting
31 participants
Started: Apr 7, 2020 · Completed: Dec 31, 2027
1 condition
1 sponsor
7 locations
NCT04201223
Family Lifestyles, Actions, and Risk Education Intervention: Version 2
NA
Active, not recruiting
762 participants
Started: Apr 7, 2020 · Completed: Jan 31, 2025
2 conditions
2 sponsors
1 location
NCT06365190
Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease
NA
Active, not recruiting
47 participants
Started: Apr 6, 2020 · Completed: Jul 31, 2024
2 conditions
1 sponsor
1 location
NCT04522076
Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia
N/A
Active, not recruiting
1,130 participants
Started: Apr 6, 2020 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT04330820
Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
PHASE1/PHASE2
Active, not recruiting
55 participants
Started: Apr 6, 2020 · Completed: Aug 31, 2025
2 conditions
2 sponsors
12 locations
NCT07070908
Modifications to Gastric Sleeve: Implications for GRED and Quality of Life
NA
Active, not recruiting
120 participants
Started: Apr 6, 2020 · Completed: Dec 31, 2025
4 conditions
2 sponsors
1 location
NCT04271540
MIcrovascular dysfuNction In Moderate-severe Psoriasis
PHASE4
Active, not recruiting
36 participants
Started: Apr 4, 2020 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT04350502
Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections
NA
Active, not recruiting
11 participants
Started: Apr 4, 2020 · Completed: Sep 12, 2025
5 conditions
1 sponsor
1 location
NCT04253262
A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
PHASE1/PHASE2
Active, not recruiting
13 participants
Started: Apr 3, 2020 · Completed: Jan 31, 2027
1 condition
5 sponsors
2 locations
NCT05110911
Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection
N/A
Active, not recruiting
1,500 participants
Started: Apr 2, 2020 · Completed: Jun 30, 2025
2 conditions
8 sponsors
6 locations
NCT05181488
Intraoperative Radiation Therapy for Resectable Pancreatic Cancer
NA
Active, not recruiting
80 participants
Started: Apr 2, 2020 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT06929884
Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World Study
N/A
Active, not recruiting
400 participants
Started: Apr 2, 2020 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT04322162
Addressing Sleep Apnea Post-Stroke/TIA
NA
Active, not recruiting
6 participants
Started: Apr 2, 2020 · Completed: Jul 31, 2024
3 conditions
1 sponsor
2 locations
NCT04162210
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE3
Active, not recruiting
325 participants
Started: Apr 2, 2020 · Completed: Jul 1, 2026
1 condition
1 sponsor
136 locations
NCT05229029
RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy
PHASE2
Active, not recruiting
196 participants
Started: Apr 2, 2020 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05671900
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer
NA
Active, not recruiting
70 participants
Started: Apr 1, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06795880
"Artificial Intelligence-Based Data Analysis Results and Mortality Prediction in Covid-19 Patients in Intensive Care"
N/A
Active, not recruiting
400 participants
Started: Apr 1, 2020 · Completed: Apr 1, 2025
1 condition
1 sponsor
1 location
NCT04964830
Sleep, Upper Airway and Dental Occlusion in Children With Large Overjet
NA
Active, not recruiting
69 participants
Started: Apr 1, 2020 · Completed: Dec 31, 2025
1 condition
9 sponsors
1 location
NCT04336228
The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
PHASE4
Active, not recruiting
46 participants
Started: Apr 1, 2020 · Completed: Dec 31, 2027
2 conditions
3 sponsors
1 location
NCT04167540
GDNF Gene Therapy for Parkinson's Disease
PHASE1
Active, not recruiting
11 participants
Started: Apr 1, 2020 · Completed: Jun 30, 2027
1 condition
3 sponsors
3 locations
NCT04116671
Stimulation Combined With Powered Motorized Orthoses for Walking After Stroke
NA
Active, not recruiting
5 participants
Started: Apr 1, 2020 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
NCT04288089
A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer
PHASE1
Active, not recruiting
31 participants
Started: Apr 1, 2020 · Completed: Mar 31, 2026
3 conditions
1 sponsor
8 locations
NCT04267926
MitoQ for Fatigue in Multiple Sclerosis (MS)
PHASE1/PHASE2
Active, not recruiting
47 participants
Started: Apr 1, 2020 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT04371081
Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance
N/A
Active, not recruiting
70 participants
Started: Apr 1, 2020 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT04105036
Social Deprivation Assessment in Older Adults
N/A
Active, not recruiting
30,000 participants
Started: Apr 1, 2020 · Completed: Mar 1, 2025
2 conditions
1 sponsor
1 location
NCT06835933
Postoperative Gastroesophageal Reflux Symptoms After Laparoscopic Sleeve Gastrectomy Based on the Presence of Preoperative Symptoms
N/A
Active, not recruiting
64 participants
Started: Apr 1, 2020 · Completed: Aug 31, 2025
3 conditions
1 sponsor
1 location
NCT06620159
Lymphocyte to Procalcitonin Ratio in Covid-19 Patients
N/A
Active, not recruiting
535 participants
Started: Apr 1, 2020 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT03477604
A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)
NA
Active, not recruiting
177 participants
Started: Mar 31, 2020 · Completed: Mar 31, 2028
1 condition
1 sponsor
21 locations
NCT04136353
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
PHASE3
Active, not recruiting
1,100 participants
Started: Mar 31, 2020 · Completed: Jul 31, 2028
1 condition
7 sponsors
93 locations
NCT04022980
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
PHASE1
Active, not recruiting
14 participants
Started: Mar 31, 2020 · Completed: Dec 31, 2025
2 conditions
3 sponsors
4 locations
NCT03987360
Educational and Cultural Engagement and Incidence of Health Adverse Events
N/A
Active, not recruiting
30,000 participants
Started: Mar 31, 2020 · Completed: Jul 31, 2025
3 conditions
1 sponsor
1 location
NCT04354246
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
PHASE1
Active, not recruiting
110 participants
Started: Mar 31, 2020 · Completed: Dec 30, 2025
9 conditions
1 sponsor
9 locations
NCT04318938
Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping
PHASE2
Active, not recruiting
118 participants
Started: Mar 30, 2020 · Completed: Jan 16, 2026
1 condition
3 sponsors
26 locations
NCT04441502
Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic
N/A
Active, not recruiting
204 participants
Started: Mar 30, 2020 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04329325
Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
PHASE2
Active, not recruiting
17 participants
Started: Mar 30, 2020 · Completed: Mar 31, 2026
2 conditions
2 sponsors
2 locations
NCT04293523
A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health
N/A
Active, not recruiting
427 participants
Started: Mar 30, 2020 · Completed: Apr 30, 2026
1 condition
1 sponsor
53 locations
NCT04223856
Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
PHASE3
Active, not recruiting
886 participants
Started: Mar 30, 2020 · Completed: Mar 1, 2028
1 condition
3 sponsors
260 locations
NCT04183465
Physical Activity Intervention in ELderly Patients With Myocardial INfarction
NA
Active, not recruiting
512 participants
Started: Mar 27, 2020 · Completed: Nov 30, 2026
2 conditions
3 sponsors
7 locations
NCT04946812
Split-belt Treadmill Training to Rehabilitate Freezing of Gait and Balance in Parkinson's Disease
NA
Active, not recruiting
28 participants
Started: Mar 27, 2020 · Completed: Mar 31, 2025
3 conditions
1 sponsor
1 location
NCT04102020
A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
PHASE3
Active, not recruiting
112 participants
Started: Mar 26, 2020 · Completed: Jun 30, 2026
1 condition
2 sponsors
156 locations
NCT04465409
Evaluation of Safety and Efficacy of Intrastromal Implantation of CorVision® Bioengineered Corneal Inlay for Correction of Presbyopia.
NA
Active, not recruiting
110 participants
Started: Mar 25, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04416490
Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer
N/A
Active, not recruiting
2,013 participants
Started: Mar 25, 2020 · Completed: Feb 28, 2027
2 conditions
1 sponsor
1 location
NCT04315571
Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents
NA
Active, not recruiting
68 participants
Started: Mar 24, 2020 · Completed: Apr 1, 2027
2 conditions
2 sponsors
1 location
NCT04277637
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
PHASE1
Active, not recruiting
437 participants
Started: Mar 24, 2020 · Completed: Aug 30, 2027
1 condition
1 sponsor
44 locations
NCT04331509
COVID-19 Symptom Tracker
N/A
Active, not recruiting
10,000,000 participants
Started: Mar 23, 2020 · Completed: Mar 23, 2026
1 condition
5 sponsors
2 locations
NCT03068741
Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)
PHASE4
Active, not recruiting
2,040 participants
Started: Mar 23, 2020 · Completed: Dec 31, 2025
1 condition
3 sponsors
4 locations
NCT04904692
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
N/A
Active, not recruiting
109 participants
Started: Mar 23, 2020 · Completed: Sep 30, 2024
1 condition
4 sponsors
3 locations
Previous
1
More pages
283
284
285
286
287
288
289
More pages
431
Next